pd 128907 has been researched along with lisuride in 1 studies
| Studies (pd 128907) | Trials (pd 128907) | Recent Studies (post-2010) (pd 128907) | Studies (lisuride) | Trials (lisuride) | Recent Studies (post-2010) (lisuride) |
|---|---|---|---|---|---|
| 16 | 0 | 9 | 756 | 80 | 31 |
| Protein | Taxonomy | pd 128907 (IC50) | lisuride (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.02 | |
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.041 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.559 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0003 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.016 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0029 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0005 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0043 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0005 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.173 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.04 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.041 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.003 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.02 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0005 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.16 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0002 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0051 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boeckler, F; Gmeiner, P; Hübner, H; Lehmann, T; Ohnmacht, U; Utz, W | 1 |
1 other study(ies) available for pd 128907 and lisuride
| Article | Year |
|---|---|
CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.
Topics: Animals; Binding Sites; Cattle; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Humans; Indolizines; Models, Molecular; Molecular Conformation; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Stereoisomerism | 2005 |